Navigation Links
Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
Date:2/11/2008

utton site, and 2,500 at its Chelsea site.

"The efficiency and flexibility of this technique is impressive," adds Warrington, "and we hope to be able to expand the use of this cutting-edge technology to become a routine treatment method in the future."

In addition to the new Desktop 7 software, Elekta's VMAT solution includes the MOSAIQ(TM) image-enabled oncology Electronic Medical Records (EMR) system and ERGO++, the first treatment planning system to use inverse planning techniques for rotational therapy. These innovations are now available as upgrade packages for all existing Elekta accelerators.

*Elekta Volumetric Intensity Modulated Arc Therapy (VMAT) is pending regulatory approvals in certain markets, including 510(k) clearance in the US, and is not yet available for commercial sale in the US.

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state-of-the-art tools to fight serious disease.

Elekta provides advanced clinical solutions and comprehensive management and information systems, as well as services for improved cancer care and management of brain disorders.

Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife(R) for non-invasive treatment of brain disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and image guided radiation therapy and radiosurgery, as well as the MOSAIQ(TM) suite of software for image-enabled EMR and efficient management of clinical and patient data.

With more than 2,000 employees globally, Elekta corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb.


'/>"/>
SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related biology technology :

1. Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
2. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
3. Elekta Negotiates To Acquire CMS
4. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
5. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
6. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
7. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
8. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
9. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
10. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
11. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., ,, BETHESDA, Md., Nov. 19 /PRNewswire-Fir...an innovator in biotechnology for diabetes therapy...lting services to food, supplement, biotechnology ...losed the previously reported $6.3 million registe... 2,760,870 shares of its common stock and warrants...
(Date:11/19/2009)...MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeuti...tient in a randomized Phase 2B study of AEG35156, ...lopment for multiple oncology indications. ,, T... 2 Study of the X-Linked Inhibitor of Apoptosis (X...High-dose Cytarabine and Idarubicin in AML Followi...
(Date:11/18/2009)...AVIS, Calif., Nov. 18 Marrone Bio ...lopment and commercialization of effective and env... announced that it has been named an IC20 company ...t and largest national angel investing group. ,... leading to rewarding results for all stakeholders...
(Date:11/18/2009)... RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ ...unced today that data from the University of Penns...y of Sangamo,s zinc finger nuclease (ZFN) based pr...nd prematurely disclosed on the internet. ,, Da...rsity of Pennsylvania School of Medicine from a si...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2
... Even with layoff announcements...employment continued to increase in September, gai...th it seemed like no one was searching for those n...ocus) October 31, 2008 -- Strong growth continues ...0 jobs created each month. Even with layoff announ...
...GO, Oct. 30 Accumetrics, Inc. has appointed,Timot...ecutive Officer. Mr.,Still has been serving in the... for the company since earlier this year., "Tim h...and startup,experience for our Board," says Tony A... Executive Chairman of the Board at Accumetrics. "...
...GE, Mass., Oct. 30 Idenix,Pharmaceuticals, Inc. (...ed,in the discovery and development of drugs for t...iseases, today reported unaudited financial result...ember 30, 2008. At,September 30, 2008, Idenix,s ca...aled approximately $60.1 million., 2008 Year-to-D...
Other Biology Technology:The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 3Timothy I. Still Appointed CEO at Accumetrics 2Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 2Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 3Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 4Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 5Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 6Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 7
(Date:11/19/2009)...ISON This week, scientists are revealing the gene... cereal crops. Corn, or maize, has one of the most...ersity of Wisconsin-Madison genomicist David Schwa...rticle in the journal Science . , "The maize ge... dead-ends that have troubled would-be sequencers ...
(Date:11/19/2009)... , WALL, N.J., Nov. 19 /PRNewswire-FirstCal...ard: BKYI), a leader in wireless public safety and...announced that the Special Shareholder Meeting hel...en because a quorum was not present. ,, (Logo: ...EYLOGO) ,, While an impressive 99.3% of the 35 ...
(Date:11/19/2009)...ACA, N.Y. - A new study of maize has identified th...le portions of the genome. New techniques may allo...iation to identify desirable traits and create new..., Publishing in the Nov. 19 issue of Science , t...at Cornell, have identified the first map of haplo...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3New map of variation in maize genetics holds promise for developing new varieties 2Dendreon Announces Webcast Presentations at Upcoming Investor Conferences 12482 1Bart Peterson to Join Lilly Leadership Team 48032 1Bart Peterson to Join Lilly Leadership Team 48032 2Bart Peterson to Join Lilly Leadership Team 48032 3Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting 12481 1Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting 12481 2
...p revolutionary drug delivery methods that are mor...ions of patients. , Chemists at The University of... drugs in plastics, using methods that do not dama...ical drugs which are at the cutting edge of modern...ting drugs can use high temperatures and harsh sol...
...ional (CI) today announced a partnership with Toyo...than 4,000 acres of the Philippines Peablanca Prot...e Northeastern part of one of the nations main isl...l communities will receive additional benefits fro...ment. , The site was chosen to launch the partner...
...he Neanderthals died out because of competition wi...tic conditions. Although scientists have gained in...icult to pinpoint the climatic character at the ti...y an international team of researchers, published ...eveloped a breakthrough approach to address this i...
Other Biology News:Using green chemistry to deliver cutting-edge drugs 2Using green chemistry to deliver cutting-edge drugs 3Using green chemistry to deliver cutting-edge drugs 4Conservation International and Toyota partner to protect Philippines' rain forests 2Conservation International and Toyota partner to protect Philippines' rain forests 3Climate -- no smoking gun for Neanderthals 2
...nterferons are cytopathic effect inhibition assays...types include; tissue culture supernatents; serum ...se assays, one unit is defined as the quantity of ...ytopathic effect of viral infection by 50%. All ...
Guanylyltransferase (5 U/l) from Ambion
...Nebulizers are available in two product models - t...se two models is that the 6000AT+ includes a membr...er aerosol for improved detection limits and reduc...tion limits for a range of elements by 10-40 times...
...Nebulizers are available in two product models - t...se two models is that the 6000AT+ includes a membr...er aerosol for improved detection limits and reduc...tion limits for a range of elements by 10-40 times...
Biology Products: